UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function

The Journal of immunology (1950), 2003-09, Vol.171 (5), p.2366-2373

2003

Volltextzugriff (PDF)

Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells

Cancer gene therapy, 2013-08, Vol.20 (8), p.469-477

2013

Volltextzugriff (PDF)

Killer dendritic cells: mechanisms of action and therapeutic implications for cancer

Cell death and differentiation, 2008-01, Vol.15 (1), p.51-57

2008

Volltextzugriff (PDF)

Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32

Cancer gene therapy, 2011-09, Vol.18 (9), p.663-673

2011

Volltextzugriff (PDF)

Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine

Molecular immunology, 2009-02, Vol.46 (5), p.893-901

2009

Volltextzugriff (PDF)

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

The Journal of experimental medicine, 1996-01, Vol.183 (1), p.283-287

1996

Volltextzugriff (PDF)

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

Nature medicine, 1995-12, Vol.1 (12), p.1297-1302

1995

Volltextzugriff (PDF)

EBV‐Specific CD8+ T Cell Reactivation in Transplant Patients Results in Expansion of CD8+ Type‐1 Regulatory T Cells

American journal of transplantation, 2007-05, Vol.7 (5), p.1215-1223

2007

Volltextzugriff (PDF)

LB1014 Sensory nerves impede anti-melanoma immune responses

Journal of investigative dermatology, 2024-08, Vol.144 (8), p.S180-S180

2024

Volltextzugriff (PDF)

Translational Mini-Review Series on Vaccines: Dendritic cell-based vaccines in renal cancer

Clinical and experimental immunology, 2007-03, Vol.147 (3), p.395-400

2007

Volltextzugriff (PDF)

Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity

Gene therapy, 2007-06, Vol.14 (11), p.863-871

2007

Volltextzugriff (PDF)

EphA2 as a Glioma-Associated Antigen: A Novel Target for Glioma Vaccines

Neoplasia (New York, N.Y.), 2005-08, Vol.7 (8), p.717-722

2005

Volltextzugriff (PDF)

NY-ESO-1 encodes DRB10401-restricted epitopes recognized by melanoma-reactive CD4+ T cells

Cancer research (Chicago, Ill.), 2000-09, Vol.60 (17), p.4946-4952

2000

Volltextzugriff (PDF)

Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity

Cancer gene therapy, 2009-12, Vol.16 (12), p.883-891

2009

Volltextzugriff (PDF)

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo

Cancer research (Chicago, Ill.), 1994, Vol.54 (1), p.182-189

1994

Volltextzugriff (PDF)

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

The Journal of experimental medicine, 1996-01, Vol.183 (1), p.87-97

1996

Volltextzugriff (PDF)

Generation of Anti-p53 Cytotoxic T Lymphocytes from Human Peripheral Blood Using Autologous Dendritic Cells

Clinical cancer research, 1999-06, Vol.5 (6), p.1281-1288

1999

Volltextzugriff (PDF)

DNA Immunization Targeting the Skin: Molecular Control of Adaptive Immunity

Journal of investigative dermatology, 1998-08, Vol.111 (2), p.183-188

1998

Volltextzugriff (PDF)

Direct transfection and activation of human cutaneous dendritic cells

Gene therapy, 2001-04, Vol.8 (8), p.608-617

2001

Volltextzugriff (PDF)

Binding and Uptake of Agalactosyl IgG by Mannose Receptor on Macrophages and Dendritic Cells

The Journal of immunology (1950), 1999-11, Vol.163 (10), p.5427-5434

1999

Volltextzugriff (PDF)

Dendritic Cells Transduced with an Adenovirus Vector Encoding Epstein-Barr Virus Latent Membrane Protein 2B: a New Modality for Vaccination

Journal of Virology, 1999-12, Vol.73 (12), p.10416-10425

1999

Volltextzugriff (PDF)

Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. I. Involvement of an Apoptosis-Inducing Pathway

The Journal of immunology (1950), 2002-02, Vol.168 (4), p.1823-1830

2002

Volltextzugriff (PDF)

Reversal of Natural Killing Susceptibility in Target Cells Expressing Transfected Class I HLA Genes

Proceedings of the National Academy of Sciences - PNAS, 1989-04, Vol.86 (7), p.2361-2364

1989

Volltextzugriff (PDF)

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

The Journal of immunology (1950), 1994-08, Vol.153 (4), p.1697

1994

Volltextzugriff (PDF)

1215PT cell repertoire sequencing reveals dynamics of response to dendritic cell vaccine plus dasatinib for checkpoint blockade resistant metastatic melanoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Englisch
(177)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(127)
Humans
(104)
Immunology
(70)
Animals
(68)
Biological And Medical Sciences
(54)
Dendritic Cells - Immunology
(54)
Mice
(47)
Oncology
(47)
Medicine, Research & Experimental
(39)
Research & Experimental Medicine
(39)
Medical Sciences
(38)
Female
(37)
T-Lymphocytes, Cytotoxic - Immunology
(31)
Immunotherapy
(28)
Melanoma - Immunology
(27)
Dendritic Cells
(26)
Tumor Cells, Cultured
(25)
Tumors
(25)
Cd8-Positive T-Lymphocytes - Immunology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function

Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells

Killer dendritic cells: mechanisms of action and therapeutic implications for cancer

Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32

Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

EBV‐Specific CD8+ T Cell Reactivation in Transplant Patients Results in Expansion of CD8+ Type‐1 Regulatory T Cells

LB1014 Sensory nerves impede anti-melanoma immune responses

Translational Mini-Review Series on Vaccines: Dendritic cell-based vaccines in renal cancer

Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity

EphA2 as a Glioma-Associated Antigen: A Novel Target for Glioma Vaccines

NY-ESO-1 encodes DRB10401-restricted epitopes recognized by melanoma-reactive CD4+ T cells

Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

Generation of Anti-p53 Cytotoxic T Lymphocytes from Human Peripheral Blood Using Autologous Dendritic Cells

DNA Immunization Targeting the Skin: Molecular Control of Adaptive Immunity

Direct transfection and activation of human cutaneous dendritic cells

Binding and Uptake of Agalactosyl IgG by Mannose Receptor on Macrophages and Dendritic Cells

Dendritic Cells Transduced with an Adenovirus Vector Encoding Epstein-Barr Virus Latent Membrane Protein 2B: a New Modality for Vaccination

Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. I. Involvement of an Apoptosis-Inducing Pathway

Reversal of Natural Killing Susceptibility in Target Cells Expressing Transfected Class I HLA Genes

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

1215PT cell repertoire sequencing reveals dynamics of response to dendritic cell vaccine plus dasatinib for checkpoint blockade resistant metastatic melanoma

Suchergebnisse filtern